Breast Reconstruction in a Coronavirus Disease 2019 Hub
Overview
Authors
Affiliations
Methods: We adopted a new protocol to treat patients with breast cancer during the COVID-19 pandemic. The main goals of our protocol were to reduce the risk of COVID-19 spread for both patients and clinicians, postpone nononcologic and more advanced surgery, develop rapid recovery for early patient discharge (within 24 hours from surgery) through pain management, and finally reduce postoperative consultations.
Results: The protocol was applied to 51 patients between early March and early April 2020. After 1 month, we decided to retrospectively review our experience. We found no significant differences in terms of postoperative pain and complication rate compared with our data in the pre-COVID period.
Conclusion: Our new protocol is safe and effective, enabling tumor resection and immediate implant-based breast reconstruction, without increasing risks to the patient or staff.
COVID-associated complications after reconstructive breast surgery: a retrospective cohort study.
Bubberman J, Claessen J, Feijen M, Meesters-Caberg M, Van Kuijk S, van der Hulst R Breast Cancer Res Treat. 2023; 202(2):257-265.
PMID: 37507518 PMC: 10505595. DOI: 10.1007/s10549-023-07064-1.
Prodhan A, Islam D, Khandker S, Jamiruddin M, Abdullah A, Godman B Breast Cancer (Dove Med Press). 2023; 15:51-89.
PMID: 36733464 PMC: 9888303. DOI: 10.2147/BCTT.S390296.
Losurdo A, Lisa A, Tomatis M, Ponti A, Montemezzi S, Bonzano E Breast Cancer Res Treat. 2022; 196(1):87-95.
PMID: 36018455 PMC: 9412793. DOI: 10.1007/s10549-022-06694-1.
Effects of COVID-19 on mastectomy and breast reconstruction rates: A national surgical sample.
Rubenstein R, Stern C, Plotsker E, Haglich K, Tadros A, Mehrara B J Surg Oncol. 2022; 126(2):205-213.
PMID: 35411946 PMC: 9088456. DOI: 10.1002/jso.26889.
Shibata D, Kawate T, Komiya T, Nakamura I, Ishikawa T, Matsumura H Arch Plast Surg. 2022; 49(1):132-136.
PMID: 35086324 PMC: 8795639. DOI: 10.5999/aps.2021.01438.